Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation -: Possible involvement of the ubiquitinated Cis protein

被引:153
作者
Verdier, F
Chrétien, S
Muller, O
Varlet, P
Yoshimura, A
Gisselbrecht, S
Lacombe, C
Mayeux, P
机构
[1] Univ Paris 05, INSERM, U363, Inst Cochin Genet Mol, F-75014 Paris, France
[2] Inst Natl Transfus Sanguine, F-75015 Paris, France
[3] Kurume Univ, Inst Life Sci, Kurume, Fukuoka 839, Japan
关键词
D O I
10.1074/jbc.273.43.28185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cis is an Src homology 2 domain-containing protein, which binds to the erythropoietin receptor and decreases erythropoietin-stimulated cell proliferation. We show that Cis associates with the second tyrosine residue of the intracellular domain of the erythropoietin receptor (Tyr(401)). TWO forms of Cis with molecular masses of 32 and 37 kDa were detected, and we demonstrate that the 37-kDa protein resulted from post-translational modifications of the 32-kDa form. Anti-ubiquitin antibodies recognized the 37-kDa form of Cis and the proteasome inhibitors N-acetyl-leucyl-leucyl-norleucinal and lactacystin inhibited its degradation, showing that the 37-kDa form of Cis is a ubiquitinated protein, which seems to be rapidly degraded by the proteasome. In erythropoietin-stimulated UT-7 cells, the activation of the erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) was transient and returned to basal levels after 30-60 min of erythropoietin stimulation. In contrast, these proteins remained strongly phosphorylated, and STAT5 remained activated for at least 120 min in the presence of proteasome inhibitors. These experiments demonstrate that the proteasomes are involved in the down-regulation of the erythropoietin receptor activation signals, Because the proteasome inhibitors induced the accumulation of both the ubiquitinated form of Cis and the Cis-erythropoietin receptor complexes, our results suggest that the ubiquitinated form of Cis could be involved in the proteasome-mediated inactivation of the erythropoietin receptor.
引用
收藏
页码:28185 / 28190
页数:6
相关论文
共 45 条
[1]   SELECTIVE GROWTH-RESPONSE TO IL-3 OF A HUMAN-LEUKEMIC CELL-LINE WITH MEGAKARYOBLASTIC FEATURES [J].
AVANZI, GC ;
LISTA, P ;
GIOVINAZZO, B ;
MINIERO, R ;
SAGLIO, G ;
BENETTON, G ;
CODA, R ;
CATTORETTI, G ;
PEGORARO, L .
BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (03) :359-366
[2]   Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation [J].
Chretien, S ;
Varlet, P ;
Verdier, F ;
Gobert, S ;
Cartron, JP ;
Gisselbrecht, S ;
Mayeux, P ;
Lacombe, C .
EMBO JOURNAL, 1996, 15 (16) :4174-4181
[3]  
COUX O, 1996, ANNU REV BIOCHEM, V65, P807
[4]  
Damen JE, 1996, EXP HEMATOL, V24, P1455
[5]  
DAMEN JE, 1993, BLOOD, V81, P3204
[6]   TYROSINE-343 IN THE ERYTHROPOIETIN RECEPTOR POSITIVELY REGULATES ERYTHROPOIETIN-INDUCED CELL-PROLIFERATION AND STAT5 ACTIVATION [J].
DAMEN, JE ;
WAKAO, H ;
MIYAJIMA, A ;
KROSL, J ;
HUMPHRIES, RK ;
CUTLER, RL ;
KRYSTAL, G .
EMBO JOURNAL, 1995, 14 (22) :5557-5568
[7]   GROWTH OF FACTOR-DEPENDENT HEMATOPOIETIC PRECURSOR CELL-LINES [J].
DEXTER, TM ;
GARLAND, J ;
SCOTT, D ;
SCOLNICK, E ;
METCALF, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 152 (04) :1036-1047
[8]  
DUSANTERFOURT I, 1992, J BIOL CHEM, V267, P10670
[9]   A new protein containing an SH2 domain that inhibits JAK kinases [J].
Endo, TA ;
Masuhara, M ;
Yokouchi, M ;
Suzuki, R ;
Sakamoto, H ;
Mitsui, K ;
Matsumoto, A ;
Tanimura, S ;
Ohtsubo, M ;
Misawa, H ;
Miyazaki, T ;
Leonor, N ;
Taniguchi, T ;
Fujita, T ;
Kanakura, Y ;
Komiya, S ;
Yoshimura, A .
NATURE, 1997, 387 (6636) :921-924
[10]   TYROSINE PHOSPHORYLATION OF THE ERYTHROPOIETIN RECEPTOR - ROLE FOR DIFFERENTIATION AND MITOGENIC SIGNAL-TRANSDUCTION [J].
GOBERT, S ;
PORTEU, F ;
PALLU, S ;
MULLER, O ;
SABBAH, M ;
DUSANTERFOURT, I ;
COURTOIS, G ;
LACOMBE, C ;
GISSELBRECHT, S ;
MAYEUX, P .
BLOOD, 1995, 86 (02) :598-606